Suppr超能文献

亮肽素对大鼠卵巢颗粒细胞蛋白聚糖细胞内降解的抑制作用。

Inhibition of intracellular degradation of proteoglycans by leupeptin in rat ovarian granulosa cells.

作者信息

Yanagishita M

出版信息

J Biol Chem. 1985 Sep 15;260(20):11075-82.

PMID:4030784
Abstract

Previous work (Yanagishita, M., and Hascall, V. C. (1984) J. Biol. Chem. 259, 10270-10283) has indicated that heparan sulfate (HS) proteoglycans in rat ovarian granulosa cells are degraded by two kinetically distinct pathways. Pathway 1 degrades proteoglycans rapidly with a t 1/2 approximately 25 min without generating appreciable degradative intermediates. Pathway 2 degrades proteoglycans more slowly with a t 1/2 approximately 4 h, generating distinct degradative intermediates: single HS chains of Mr = approximately 10,000 and approximately 5,000. Effects of leupeptin, an inhibitor of thiol proteases, on the intracellular degradation of proteoglycans in the rat ovarian granulosa cell culture were examined using various chase protocols after labeling cells with [35S]sulfate. The presence of leupeptin at 100 micrograms/ml in the culture medium inhibited the intracellular degradation of proteoglycans by approximately 80% during a 7-h chase period after a 20-h labeling. Leupeptin affected neither the cellular content nor the in vitro activities of beta-hexosaminidase and arylsulfatase. Structural analyses of heparan sulfate species in leupeptin-treated cells demonstrated that the drug inhibited the degradation of HS proteoglycans at two distinct points. First, degradation of the core protein was partially inhibited and delayed before the start of glycosaminoglycan degradation. This resulted in the accumulation of degradative intermediates with partially degraded core proteins bearing intact glycosaminoglycan chains. This establishes the initial sequence for HS proteoglycan degradation, with proteolysis preceding endoglycosidase digestion, and suggests that these two degradation steps may occur in physically separate compartments. Second, the final depolymerization of HS fragments through pathway 2 was totally inhibited, resulting in the continuous accumulation of Mr = 5,000 HS chains. This is not due to the direct inhibition of the lysosomal exoglycosidase and sulfatase enzymes responsible for the complete depolymerization of HS chains, since pathway 1, while slowed, continued to completely depolymerize the HS chains in the presence of leupeptin. The results suggest that the intracellular compartment which completely degrades heparan sulfate chains is separate from those containing partially, endoglycosidically processed heparan sulfate chains and that leupeptin interfered with the translocation of glycosaminoglycans to the final degradation site.

摘要

先前的研究工作(柳下田,M.,和哈斯卡尔,V. C.(1984年)《生物化学杂志》259,10270 - 10283)表明,大鼠卵巢颗粒细胞中的硫酸乙酰肝素(HS)蛋白聚糖通过两条动力学上不同的途径降解。途径1快速降解蛋白聚糖,半衰期约为25分钟,且不会产生明显的降解中间体。途径2降解蛋白聚糖的速度较慢,半衰期约为4小时,会产生不同的降解中间体:分子量约为10,000和5,000的单个HS链。在用[35S]硫酸盐标记细胞后,使用各种追踪方案研究了硫醇蛋白酶抑制剂亮抑酶肽对大鼠卵巢颗粒细胞培养物中蛋白聚糖细胞内降解的影响。在20小时标记后的7小时追踪期内,培养基中100微克/毫升的亮抑酶肽存在时,抑制了蛋白聚糖的细胞内降解约80%。亮抑酶肽既不影响β - 己糖胺酶和芳基硫酸酯酶的细胞含量,也不影响其体外活性。对亮抑酶肽处理细胞中的硫酸乙酰肝素种类进行结构分析表明,该药物在两个不同点抑制了HS蛋白聚糖的降解。首先,在糖胺聚糖降解开始之前,核心蛋白的降解受到部分抑制并延迟。这导致了带有完整糖胺聚糖链的部分降解核心蛋白的降解中间体的积累。这确定了HS蛋白聚糖降解的初始顺序,即蛋白水解先于内切糖苷酶消化,并表明这两个降解步骤可能发生在物理上分开的区室中。其次,途径2中HS片段的最终解聚被完全抑制,导致分子量为5,000的HS链持续积累。这不是由于直接抑制负责HS链完全解聚的溶酶体外切糖苷酶和硫酸酯酶,因为在亮抑酶肽存在的情况下,途径1虽然减慢,但仍继续使HS链完全解聚。结果表明,完全降解硫酸乙酰肝素链的细胞内区室与含有部分经内切糖苷酶处理的硫酸乙酰肝素链的区室是分开的,并且亮抑酶肽干扰了糖胺聚糖向最终降解位点的转运。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验